-
Interferons Superior to Glatiramer Acetate, and Tysabri More Effective than Gilenya for RRMS, Real-world Study Finds
A real-world a study in Poland will examine treatment with interferon beta, glatiramer acetate, Tysabri and Gilenya in RRMS patients. Read more about the study here.
Are you interested in following this study as it progresses?
Sorry, there were no replies found.
Log in to reply.